Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders
Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocamp...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/151826 |
| Aporte de: |
| id |
I19-R120-10915-151826 |
|---|---|
| record_format |
dspace |
| spelling |
I19-R120-10915-1518262023-04-20T04:08:31Z http://sedici.unlp.edu.ar/handle/10915/151826 issn:1876-7958 Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders Chiavellini, Priscila Canatelli Mallat, Martina Lehmann, Marianne Goya, Rodolfo Gustavo Morel, Gustavo Ramón 2021-08-04 2023-04-19T18:54:24Z en Ciencias Médicas aging Alzheimer’s disease cell reprogramming epilepsy gene therapy glial cell line-derived neurotrophic factor hippocampus major depression Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocampal function leads to epilepsy and mood disorders. In the first section, we summarized the most salient knowledge on the role of glial cell-line-derived neurotrophic factor and its receptors focused on aging, cognition and neurodegenerative and hippocampal-related neurological diseases mentioned above. In the second section, we reviewed the therapeutic approaches, particularly gene therapy, using glial cell-line-derived neurotrophic factor or its gene, as a key molecule in the development of neurological disorders. In the third section, we pointed at the potential of regenerative medicine, as an emerging and less explored strategy for the treatment of hippocampal disorders. We briefly reviewed the use of partial reprogramming to restore brain functions, non-neuronal cell reprogramming to generate neural stem cells, and neural progenitor cells as source-specific neuronal types to be implanted in animal models of specific neurodegenerative disorders. Instituto de Investigaciones Bioquímicas de La Plata Articulo Articulo http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf 469-476 |
| institution |
Universidad Nacional de La Plata |
| institution_str |
I-19 |
| repository_str |
R-120 |
| collection |
SEDICI (UNLP) |
| language |
Inglés |
| topic |
Ciencias Médicas aging Alzheimer’s disease cell reprogramming epilepsy gene therapy glial cell line-derived neurotrophic factor hippocampus major depression |
| spellingShingle |
Ciencias Médicas aging Alzheimer’s disease cell reprogramming epilepsy gene therapy glial cell line-derived neurotrophic factor hippocampus major depression Chiavellini, Priscila Canatelli Mallat, Martina Lehmann, Marianne Goya, Rodolfo Gustavo Morel, Gustavo Ramón Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| topic_facet |
Ciencias Médicas aging Alzheimer’s disease cell reprogramming epilepsy gene therapy glial cell line-derived neurotrophic factor hippocampus major depression |
| description |
Hippocampus serves as a pivotal role in cognitive and emotional processes, as well as in the regulation of the hypothalamus-pituitary axis. It is known to undergo mild neurodegenerative changes during normal aging and severe atrophy in Alzheimer’s disease. Furthermore, dysregulation in the hippocampal function leads to epilepsy and mood disorders. In the first section, we summarized the most salient knowledge on the role of glial cell-line-derived neurotrophic factor and its receptors focused on aging, cognition and neurodegenerative and hippocampal-related neurological diseases mentioned above. In the second section, we reviewed the therapeutic approaches, particularly gene therapy, using glial cell-line-derived neurotrophic factor or its gene, as a key molecule in the development of neurological disorders. In the third section, we pointed at the potential of regenerative medicine, as an emerging and less explored strategy for the treatment of hippocampal disorders. We briefly reviewed the use of partial reprogramming to restore brain functions, non-neuronal cell reprogramming to generate neural stem cells, and neural progenitor cells as source-specific neuronal types to be implanted in animal models of specific neurodegenerative disorders. |
| format |
Articulo Articulo |
| author |
Chiavellini, Priscila Canatelli Mallat, Martina Lehmann, Marianne Goya, Rodolfo Gustavo Morel, Gustavo Ramón |
| author_facet |
Chiavellini, Priscila Canatelli Mallat, Martina Lehmann, Marianne Goya, Rodolfo Gustavo Morel, Gustavo Ramón |
| author_sort |
Chiavellini, Priscila |
| title |
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| title_short |
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| title_full |
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| title_fullStr |
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| title_full_unstemmed |
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| title_sort |
therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders |
| publishDate |
2021 |
| url |
http://sedici.unlp.edu.ar/handle/10915/151826 |
| work_keys_str_mv |
AT chiavellinipriscila therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders AT canatellimallatmartina therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders AT lehmannmarianne therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders AT goyarodolfogustavo therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders AT morelgustavoramon therapeuticpotentialofglialcelllinederivedneurotrophicfactorandcellreprogrammingforhippocampalrelatedneurologicaldisorders |
| _version_ |
1765660031161729024 |